ropinirole has been researched along with Serotonin Syndrome in 2 studies
Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.
Excerpt | Relevance | Reference |
---|---|---|
"Two stroke patients were administered ropinirole (patient 1) and carbidopa/levodopa (patient 2) during rehabilitation." | 3.81 | Serotonin syndrome in stroke patients. ( Chang, MC; Jang, SH; Kwon, YM, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pagonabarraga, J | 1 |
Kulisevsky, J | 1 |
Jang, SH | 1 |
Kwon, YM | 1 |
Chang, MC | 1 |
1 review available for ropinirole and Serotonin Syndrome
Article | Year |
---|---|
[Dopaminergic treatment in Parkinson's disease: what has each therapeutic family got to offer?].
Topics: Amantadine; Antiparkinson Agents; Cardiovascular Diseases; Catechol O-Methyltransferase; Catechol O- | 2014 |
1 other study available for ropinirole and Serotonin Syndrome
Article | Year |
---|---|
Serotonin syndrome in stroke patients.
Topics: Carbidopa; Dopamine Agonists; Drug Combinations; Humans; Indoles; Levodopa; Male; Middle Aged; Serot | 2015 |